EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Effectiveness and Safety of a Polycaprolactone-Based Dermal Filler for Correction of Temple Hollowing in Chinese Adults: A Multicenter Randomized Controlled Study

Yan Wu, Meng-Long Ran, Wei-Jin Hong, Miao-Jian Wan, Zi-Jian Gong, Ai-Jun Zhang, Yan-Ping Guo, Hong-Sen Bi, Xu Chang, Hang Wang, Ge Feng, Nan Dai, Meng Yan, Zhong-Xing Zhang, Sheng-Kang Luo

Aesthetic Surgery Journal Open Forum · 2026-10-31

DOI: 10.1093/asjof/ojag217 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Temple hollowing is a common sign of facial aging. Evidence for durable correction with polycaprolactone (PCL)-based dermal fillers in this indication remains limited. Objectives To evaluate the effectiveness and safety of a PCL-based dermal filler for correction of flat to severe temple hollowing in Chinese adults. Methods In this prospective, multicenter, randomized, evaluator-blinded trial, subjects with Allergan Temple Hollowing Scale (ATHS) scores of 1-4 were randomized 2:1 to receive bilateral filler injections or no treatment. Optional touch-up was allowed at Month 1. The primary endpoint was the blinded investigator-assessed ATHS response rate at Month 12 after the last injection or randomization, defined as a ≥ 1-point bilateral improvement from baseline. Secondary endpoints included GAIS improvement, subject satisfaction, injection investigator-assessed ATHS response, and third-party blinded panel photographic assessment. Safety was monitored. Results 161 subjects were randomized. The ATHS response rate was higher in the treatment group at Month 12 (90.6% vs. 0.0%). Efficacy was maintained through Month 18 in the treatment group, with sustained aesthetic improvement and high subject satisfaction. GAIS improvement exceeded 94% at all visits. No serious treatment-related events were reported. Conclusions This PCL-based dermal filler demonstrated significant and durable improvement and was well tolerated for correction of flat to severe temple hollowing in Chinese adults through 18 months.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →